ATE218881T1 - Pharmazeutische zusammensetzung mit mutiertem tyrosin 353 ezrin - Google Patents

Pharmazeutische zusammensetzung mit mutiertem tyrosin 353 ezrin

Info

Publication number: ATE218881T1
Authority: AT; Austria
Prior art keywords: pharmaceutical composition; composition containing; ezrine; containing mutated; mutated tyrosine
Prior art date: 1998-03-18

Application number

AT99917867T

Other languages

English (en)

Inventor

Monique Arpin

Tiziana Crepaldi

Alexis Gautreau

Daniel Louvard

Original Assignee

Inst Curie

Centre Nat Rech Scient

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-18

Filing date

1999-03-18

Publication date

2002-06-15

1999-03-18 Application filed by Inst Curie, Centre Nat Rech Scient filed Critical Inst Curie

2002-06-15 Application granted granted Critical

2002-06-15 Publication of ATE218881T1 publication Critical patent/ATE218881T1/de

Links

OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 title abstract 2
102100020903 Ezrin Human genes 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
108010055671 ezrin Proteins 0.000 abstract 1
239000012634 fragment Substances 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Marine Sciences & Fisheries (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT99917867T 1998-03-18 1999-03-18 Pharmazeutische zusammensetzung mit mutiertem tyrosin 353 ezrin ATE218881T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/040,725 US6399584B1 (en)	1998-03-18	1998-03-18	Pharmaceutical composition containing ezrin mutated on tyrosine 353
PCT/EP1999/002054 WO1999047150A2 (en)	1998-03-18	1999-03-18	A pharmaceutical composition containing ezrin mutated on tyrosine 353

Publications (1)

Publication Number	Publication Date
ATE218881T1 true ATE218881T1 (de)	2002-06-15

Family

ID=21912598

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99917867T ATE218881T1 (de)	1998-03-18	1999-03-18	Pharmazeutische zusammensetzung mit mutiertem tyrosin 353 ezrin

Country Status (6)

Country	Link
US (2)	US6399584B1 (de)
EP (1)	EP1061941B1 (de)
AT (1)	ATE218881T1 (de)
AU (1)	AU3600199A (de)
DE (1)	DE69901805T2 (de)
WO (1)	WO1999047150A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2354241A (en) *	1999-09-17	2001-03-21	Rupert Donald Holms	Regulatory/unfolding peptides of ezrin
CA2446458A1 (en)	2001-05-09	2002-11-14	Yale University	Toll/interleukin-1 receptor adaptor protein (tirap)
US20040105860A1 (en) *	2002-08-01	2004-06-03	Losordo Douglas W.	Cell modulation using a cytoskeletal protein
CA2522460A1 (en) *	2003-04-30	2004-11-11	Applied Research Systems Ars Holding N.V.	Beta-amyloid inhibitors and use thereof
WO2005060996A2 (en) *	2003-12-23	2005-07-07	Lauras As	Method of altering the pka type i signalling pathway
ATE511848T1 (de) *	2004-08-25	2011-06-15	Us Gov Health & Human Serv	Lebendige mikrobielle mikrobizide
CA2569080A1 (en) *	2006-11-20	2008-05-20	Institut Pasteur	Anti-coronavirus molecules and their use in compositions and methods for treating and/or preventing infection caused by a coronavirus
WO2009103312A1 (en) *	2008-02-19	2009-08-27	Ludwig-Maximilians-Universität	Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis and poststreptococcal diseases
US9127077B2 (en)	2009-09-23	2015-09-08	L'universite Paris Descartes	Polypeptides and nucleic acids for treating ErbB2-dependent cancers

1998
- 1998-03-18 US US09/040,725 patent/US6399584B1/en not_active Expired - Fee Related
1999
- 1999-03-18 DE DE69901805T patent/DE69901805T2/de not_active Expired - Fee Related
- 1999-03-18 EP EP99917867A patent/EP1061941B1/de not_active Expired - Lifetime
- 1999-03-18 AU AU36001/99A patent/AU3600199A/en not_active Abandoned
- 1999-03-18 WO PCT/EP1999/002054 patent/WO1999047150A2/en not_active Ceased
- 1999-03-18 AT AT99917867T patent/ATE218881T1/de active
2002
- 2002-04-08 US US10/118,651 patent/US20020115633A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US6399584B1 (en)	2002-06-04
EP1061941B1 (de)	2002-06-12
US20020115633A1 (en)	2002-08-22
WO1999047150A2 (en)	1999-09-23
DE69901805D1 (de)	2002-07-18
WO1999047150A3 (en)	2000-01-20
WO1999047150A9 (en)	1999-11-18
EP1061941A2 (de)	2000-12-27
AU3600199A (en)	1999-10-11
DE69901805T2 (de)	2003-03-06

Similar Documents

Publication	Publication Date	Title
PL323490A1 (en)	1998-03-30	Tetralinic compounds exibiting acitity against multgiple-drug refractoriness
NZ334124A (en)	2000-10-27	Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
AP2001002129A0 (en)	2001-06-30	5HT1 receptor agonists and metoclopramide for the treatment of migrane.
TR199901417T2 (xx)	1999-10-21	Analjezik etkisi olan yeni bile�imler.
BR9708632A (pt)	2000-01-18	Composto calcilìticos
MD960330A (ro)	1998-05-31	Compuşi nepeptidilici, compoziţie farmaceutică pe baza acestora, metodă de tratament
ID29393A (id)	2001-08-30	Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
ID26639A (id)	2001-01-25	Sediaan farmasi yang mengandung agonis reseptor angiotensin ii jenis 2 dan pemakaiannya
BR0307508A (pt)	2004-12-07	Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de tratamento de doença
SG144712A1 (en)	2008-08-28	Nordihydroguaiartic derivaties for use in treatment of tumors
ATE338771T1 (de)	2006-09-15	Antagonisten des intestinotrophen glp-2 peptides
NO20004419D0 (no)	2000-09-05	Ny anvendelse
TR199800270T1 (xx)	1998-05-21	Kanser hastal�klar�n�n ilerlemesini �nlemede flukonazol kullan�m�.
ATE212829T1 (de)	2002-02-15	Feste, wasserfreie, pharmazeutische zubereitungen für vaginale verwendung
BR0108728A (pt)	2003-12-30	Combinação farmacêutica terapêutica, e, método para tratar um c ncer.
EE03420B1 (et)	2001-06-15	Farmatseutiline kompositsioon maania ja bipolaarse häire raviks
DE69901805D1 (de)	2002-07-18	Pharmazeutische zusammensetzung mit mutiertem tyrosin 353 ezrin
DE69907926D1 (de)	2003-06-18	1,2,4-triazol-3-thion verbindungen
HU9600887D0 (en)	1996-06-28	Compounds for medicinal use
DE69711078D1 (de)	2002-04-18	Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
BR9814419A (pt)	2000-10-10	"combinação de compostos de benzociclo-heptapiridina e drogas antineopláticas para tratamento de doenças proliferativas"
NO983177L (no)	1998-07-10	Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
DE69934689D1 (de)	2007-02-15	Verwendung der protein-kinase-c-epsilon-inhibitoren zur behandlung von schmerzen
TR200000455T2 (tr)	2000-09-21	Alzheimer hastalığının tedavisinde fankinonun kullanılması.
MY126321A (en)	2006-09-29	Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.